Jazz Pharmaceuticals plc Operating Leases, Future Minimum Payments, Due in Four Years
Jazz Pharmaceuticals plc (JAZZ) had Operating Leases, Future Minimum Payments, Due in Four Years of $5.39 million as of 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2019-02-26
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $5.39M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $5.21M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $19.13M.
- 2017-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $11.33M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-12-31 | $5.39M 10-K · filed 2019-02-26 |
| 2017-12-31 | $5.21M 10-K · filed 2018-02-27 |
| 2017-09-30 | $19.13M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $11.33M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $9.56M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $9.94M 10-K · filed 2017-02-28 |
| 2016-09-30 | $10.38M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $7.25M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $7.28M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $7.17M 10-K · filed 2016-02-23 |
| 2015-09-30 | $8.05M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $7.80M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $7.83M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $1.44M 10-K · filed 2015-02-24 |
| 2014-09-30 | $4.53M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $3.96M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $3.75M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $3.19M 10-K · filed 2014-02-25 |
| 2013-09-30 | $5.40M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $4.94M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $4.13M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $4.07M 10-K · filed 2013-02-26 |
| 2012-09-30 | $5.03M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $4.96M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $2.70M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $1.00K 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |